CompletedNot Applicable

T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients

652 participantsStarted 2007-01

Plain-language summary

The purpose of this study is to provide accurate prognostic data linking cardiac complications to myocardial T2\* values (A measure of iron levels in the heart using MRI)in patients predisposed to heart iron overload.

Who can participate

Age range18 Years – 77 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Thalassaemia Major * Patient must have had a cardiac MRI scan between 1999 and 2006 Exclusion Criteria: * Other structural heart disease such as valvular abnormalities, MI, congenital heart disease

What they're measuring

Heart Failure

Timeframe: 1yr

Arrhythmia

Timeframe: 1yr

Trial details

NCT IDNCT00520559

SponsorImperial College London

Sponsor typeOTHER

Study typeOBSERVATIONAL

View on ClinicalTrials.gov More Thalassemia trials